Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lakshmi N P Voruganti

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Psychiatry & Neuroscience : JPN|June 18, 2002
What's in a name? The evolution of the nomenclature of antipsychotic drugsCaroline King, Lakshmi N P Voruganti
CNS Drugs|June 13, 2013
The impact of newer atypical antipsychotics on patient-reported outcomes in schizophreniaA George Awad, Lakshmi N P Voruganti
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 17, 2004
New antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off?A George Awad, Lakshmi N P Voruganti
Schizophrenia Research|September 5, 2006
Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia--findings from an in vivo SPECT studyLakshmi N P Voruganti, A George Awad
Pharmacoeconomics|January 18, 2008
The burden of schizophrenia on caregivers: a reviewA George Awad, Lakshmi N P Voruganti
Schizophrenia Research|July 13, 2004
Body weight, image and self-esteem evaluation questionnaire: development and validation of a new scaleA George Awad, Lakshmi N P Voruganti
CNS Drugs|November 4, 2004
Impact of atypical antipsychotics on quality of life in patients with schizophreniaA George Awad, Lakshmi N P Voruganti
Schizophrenia Research|June 27, 2002
Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophreniaLakshmi N P Voruganti, A George Awad
Pharmacoeconomics|January 24, 2012
Measuring quality of life in patients with schizophrenia: an updateA George Awad, Lakshmi N P Voruganti
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 30, 2006
Going beyond: an adventure- and recreation-based group intervention promotes well-being and weight loss in schizophreniaLakshmi N P Voruganti, Jeff Whatham, Eleanor Bard, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Psychiatry & Neuroscience : JPN|June 18, 2002
What's in a name? The evolution of the nomenclature of antipsychotic drugsCaroline King, Lakshmi N P Voruganti
CNS Drugs|June 13, 2013
The impact of newer atypical antipsychotics on patient-reported outcomes in schizophreniaA George Awad, Lakshmi N P Voruganti
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 17, 2004
New antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off?A George Awad, Lakshmi N P Voruganti
Schizophrenia Research|September 5, 2006
Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia--findings from an in vivo SPECT studyLakshmi N P Voruganti, A George Awad
Pharmacoeconomics|January 18, 2008
The burden of schizophrenia on caregivers: a reviewA George Awad, Lakshmi N P Voruganti
Schizophrenia Research|July 13, 2004
Body weight, image and self-esteem evaluation questionnaire: development and validation of a new scaleA George Awad, Lakshmi N P Voruganti
CNS Drugs|November 4, 2004
Impact of atypical antipsychotics on quality of life in patients with schizophreniaA George Awad, Lakshmi N P Voruganti
Schizophrenia Research|June 27, 2002
Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophreniaLakshmi N P Voruganti, A George Awad
Pharmacoeconomics|January 24, 2012
Measuring quality of life in patients with schizophrenia: an updateA George Awad, Lakshmi N P Voruganti
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 30, 2006
Going beyond: an adventure- and recreation-based group intervention promotes well-being and weight loss in schizophreniaLakshmi N P Voruganti, Jeff Whatham, Eleanor Bard, et al.
Pageof 1